Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.39%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
3.24 Down 0.03(0.92%) Aug 1, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   5,750   -   1,400  
Cost of Revenue -   -   -   -  
Gross Profit -   5,750   -   1,400  
Operating Expenses
Research Development16,869  18,046  17,574  19,393  
Selling General and Administrative5,516  4,648  4,677  4,892  
Non Recurring -   -  1,679   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (22,385) (16,944) (23,930) (22,885)
Income from Continuing Operations
Total Other Income/Expenses Net82  83  106  117  
Earnings Before Interest And Taxes(22,303)(16,861)(23,824)(22,768)
Interest Expense -   -   -   -  
Income Before Tax(22,303)(16,861)(23,824)(22,768)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(22,303)(16,861)(23,824)(22,768)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (22,303) (16,861) (23,824) (22,768)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (22,303) (16,861) (23,824) (22,768)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.